A share price of Insmed Inc [INSM] is currently trading at $81.01, up 4.02%. An important factor to consider is whether the stock is rising or falling in short-term value. The INSM shares have gain 3.25% over the last week, with a monthly amount glided 15.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on April 23, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research started tracking the stock with Outperform rating on February 15, 2024, and set its price target to $42. On December 08, 2023, Wells Fargo initiated with a Overweight rating and assigned a price target of $55 on the stock. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 26, 2023. Mizuho started tracking with a Buy rating for this stock on December 09, 2022, and assigned it a price target of $28. In a note dated December 07, 2022, Barclays initiated an Overweight rating and provided a target price of $37 on this stock.
Insmed Inc experienced fluctuations in its stock price throughout the past year between $21.92 and $80.63. Currently, Wall Street analysts expect the stock to reach $88.5 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $81.01 at the most recent close of the market. An investor can expect a potential return of 9.25% based on the average INSM price forecast.
Analyzing the INSM fundamentals
Trailing Twelve Months sales for Insmed Inc [NASDAQ:INSM] were 342.96M which represents 18.15% growth. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -2.14%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 12.59 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.58 points at the first support level, and at 76.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.34, and for the 2nd resistance point, it is at 83.68.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Insmed Inc [NASDAQ:INSM] is 6.37. On the other hand, the Quick Ratio is 5.99, and the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 42.26, the price to book ratio is 29.97.
Transactions by insiders
Recent insider trading involved Lewis William, Officer, that happened on Feb 03 ’25 when 25580.0 shares were purchased. Chief People Strategy Officer, Schaeffer Orlov S Nicole completed a deal on Jan 30 ’25 to sell 91140.0 shares. Meanwhile, Officer Schaeffer Orlov S Nicole bought 91140.0 shares on Jan 30 ’25.
